IkappaB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-kappaB in the central nervous system
about
Astrocytes in Oligodendrocyte Lineage Development and White Matter PathologyTranscriptional Control of Synaptic Plasticity by Transcription Factor NF-κBRole of microglia in CNS autoimmunityMultiple sclerosis: molecular mechanisms and therapeutic opportunitiesLaquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis.Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cellsMicroglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways.Interferon-γ activates nuclear factor-κ B in oligodendrocytes through a process mediated by the unfolded protein response.Host microbiota constantly control maturation and function of microglia in the CNS.USP18 lack in microglia causes destructive interferonopathy of the mouse brain.Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination.Control of IL-17 receptor signaling and tissue inflammation by the p38α-MKP-1 signaling axis in a mouse model of multiple sclerosisTransgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis.NF-κB signalling requirement for brain myelin formation is shown by genotype/MRI phenotype correlations in patients with Xq28 duplications.Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy.Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementiaMicroglial CX3CR1 promotes adult neurogenesis by inhibiting Sirt 1/p65 signaling independent of CX3CL1Transient IKK2 activation in astrocytes initiates selective non-cell-autonomous neurodegeneration.The role of IκB kinase complex in the neurobiology of Huntington's disease.Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosisNF-κB signaling regulates myelination in the CNS.NF-κB activation protects oligodendrocytes against inflammation.CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.Vinpocetine inhibits oligodendroglial precursor cell differentiation.Phosphorylation of αB-crystallin supports reactive astrogliosis in demyelination.The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination.Activation of the unfolded protein response enhances motor recovery after spinal cord injury.Dysfunctional NF-κB and brain myelin formation.Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination.Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination.Effect of glial cells on remyelination after spinal cord injury.Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.A TLR/AKT/FoxO3 immune tolerance-like pathway disrupts the repair capacity of oligodendrocyte progenitors.Inflammatory and cytotoxic effects of bifenthrin in primary microglia and organotypic hippocampal slice cultures.Role of nuclear factor κB in multiple sclerosis and experimental autoimmune encephalomyelitis
P2860
Q26744749-CEE35735-DA9D-4B7D-93CD-31EA86409834Q26765679-A751FD82-4F31-42AB-AC12-EA647645B7BAQ27003940-10DC8C5A-5CA6-4DA2-858E-65F4DA6F7FD6Q27023735-5FB99CE4-26F5-40C0-9ABE-55DCA18167B6Q31017620-3E43E7AE-F9EE-4E6C-912F-818BE3DF8093Q33930062-84F946CE-C50D-40B8-B55F-2949C4DEC33BQ34035175-E43BF857-CE51-47C2-9756-3A047B4D7AC4Q34264650-588526B2-4F52-444A-A40B-8C1DC6D8139FQ34478756-C3A32CE9-447F-4DDD-AFC0-12A9E72FCCC0Q35762623-00EF57ED-CEDE-4F57-AB81-82A33C70906FQ36068294-FD0EFF45-5C4C-4A99-9BE6-EC05A1985550Q36174480-63E57DDA-ACF4-4C16-893B-ADB2B26D8039Q36267838-8C593257-8FF3-45D0-80D1-96EFAFF52841Q36376697-1542547C-3FC5-4537-A193-3316004CFB79Q36543027-A308FE46-DEE4-4394-9AF3-7AC11DBCDD7EQ37092530-A8A24346-3C79-4EAD-8C99-56F02505B08EQ37150886-C95A619B-795A-41D7-9F0D-52AA4ECF2E72Q37263310-5592E262-6919-42BF-90DC-8090D1DD08FBQ37640563-5124EBA3-E167-4103-BC1B-C20D9A52FAD3Q37873608-650D2630-0A03-4A90-B3E9-C19CE1BCEC71Q38216015-C74A3F98-797C-4E94-9FCF-D96B76C394EDQ38218086-01C0A1F5-F4CF-44B4-8CA0-3A1DF7DC9440Q38607718-88382437-D18E-4DF0-BEA9-471850B339C1Q38779104-A152357F-63D1-4874-80D2-BBE90242E11BQ39575952-E26870DE-BFD5-4D3F-859D-38F9255507F0Q40333374-7BEB108D-1E4F-490B-BB8E-4DECE87585DFQ40603939-403A20DF-3624-4BA5-A3C9-AC05EC49266BQ42143560-AA5286F4-CCE6-4661-B908-E41FAD6A2AA2Q42575102-CDE6004C-F66C-4EB0-BD07-950A1B2A564EQ43865165-D85131DF-5013-48C9-AC19-2E9DE6573968Q44448576-3A84DF56-3B29-4302-B2B4-786CF79A2878Q47094040-663A7250-E244-41A7-948A-8D7EAFC20623Q47343678-CC312472-22BA-4E64-A4CF-39E53ADB6900Q48649157-705919AF-8817-4351-89F6-BB47054688C6Q50202910-26165CE6-A9D1-40F6-ACA4-6DA3992D97D1Q52718843-EC1B88C6-1A5D-4D01-B332-87FAFF634E37Q55424095-C61A9420-C648-4D51-9B1E-5D6E8289F32BQ58775945-32791E96-0B0B-4236-84A3-12727F2A8329
P2860
IkappaB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-kappaB in the central nervous system
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
IkappaB kinase 2 determines ol ...... in the central nervous system
@ast
IkappaB kinase 2 determines ol ...... in the central nervous system
@en
type
label
IkappaB kinase 2 determines ol ...... in the central nervous system
@ast
IkappaB kinase 2 determines ol ...... in the central nervous system
@en
prefLabel
IkappaB kinase 2 determines ol ...... in the central nervous system
@ast
IkappaB kinase 2 determines ol ...... in the central nervous system
@en
P2093
P2860
P50
P356
P1433
P1476
IkappaB kinase 2 determines ol ...... in the central nervous system
@en
P2093
Daniel Erny
Domenico Del Turco
Geert van Loo
Jenni Raasch
John R Bethea
Klaus-Peter Knobeloch
Marco Prinz
Markus Knust
Nicolas Zeller
Thomas Blank
P2860
P304
P356
10.1093/BRAIN/AWQ359
P407
P577
2011-02-10T00:00:00Z